442 related articles for article (PubMed ID: 17160610)
1. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis.
Ogrinc K; Logar M; Lotric-Furlan S; Cerar D; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2006 Nov; 118(21-22):696-701. PubMed ID: 17160610
[TBL] [Abstract][Full Text] [Related]
2. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.
Dattwyler RJ; Luft BJ; Kunkel MJ; Finkel MF; Wormser GP; Rush TJ; Grunwaldt E; Agger WA; Franklin M; Oswald D; Cockey L; Maladorno D
N Engl J Med; 1997 Jul; 337(5):289-94. PubMed ID: 9233865
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid findings in patients with symptoms suggesting chronic Lyme borreliosis.
Ogrinc K; Lotric-Furlan S; Maraspin V; Cimperman J; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):535-8. PubMed ID: 12422597
[TBL] [Abstract][Full Text] [Related]
4. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.
Klempner MS; Hu LT; Evans J; Schmid CH; Johnson GM; Trevino RP; Norton D; Levy L; Wall D; McCall J; Kosinski M; Weinstein A
N Engl J Med; 2001 Jul; 345(2):85-92. PubMed ID: 11450676
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis.
Eckman MH; Steere AC; Kalish RA; Pauker SG
N Engl J Med; 1997 Jul; 337(5):357-63. PubMed ID: 9233874
[No Abstract] [Full Text] [Related]
6. Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial.
Stupica D; Velušcek M; Blagus R; Bogovic P; Rojko T; Cerar T; Strle F
J Antimicrob Chemother; 2018 May; 73(5):1352-1358. PubMed ID: 29385444
[TBL] [Abstract][Full Text] [Related]
7. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.
Ljøstad U; Skogvoll E; Eikeland R; Midgard R; Skarpaas T; Berg A; Mygland A
Lancet Neurol; 2008 Aug; 7(8):690-5. PubMed ID: 18567539
[TBL] [Abstract][Full Text] [Related]
8. Therapy of Lyme borreliosis in children.
Krbkova L; Stanek G
Infection; 1996; 24(2):170-3. PubMed ID: 8740116
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease.
Berende A; Nieuwenhuis L; Ter Hofstede HJM; Vos FJ; Vogelaar ML; Tromp M; van Middendorp H; Donders ART; Evers AWM; Kullberg BJ; Adang EMM
PLoS One; 2018; 13(4):e0195260. PubMed ID: 29608590
[TBL] [Abstract][Full Text] [Related]
10. [Lyme borreliosis in adults].
Ljøstad U; Mygland A
Tidsskr Nor Laegeforen; 2008 May; 128(10):1175-8. PubMed ID: 18480867
[TBL] [Abstract][Full Text] [Related]
11. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial.
Wormser GP; Ramanathan R; Nowakowski J; McKenna D; Holmgren D; Visintainer P; Dornbush R; Singh B; Nadelman RB
Ann Intern Med; 2003 May; 138(9):697-704. PubMed ID: 12729423
[TBL] [Abstract][Full Text] [Related]
12. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis.
Borg R; Dotevall L; Hagberg L; Maraspin V; Lotric-Furlan S; Cimperman J; Strle F
Scand J Infect Dis; 2005; 37(6-7):449-54. PubMed ID: 16012005
[TBL] [Abstract][Full Text] [Related]
13. [Stage-oriented treatment of Lyme borreliosis].
Fingerle V; Wilske B
MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
[TBL] [Abstract][Full Text] [Related]
14. Review of treatment options for lyme borreliosis.
Taylor RS; Simpson IN
J Chemother; 2005 Sep; 17 Suppl 2():3-16. PubMed ID: 16315580
[TBL] [Abstract][Full Text] [Related]
15. Forty Years of Evidence on the Efficacy and Safety of Oral and Injectable Antibiotics for Treating Lyme Disease of Adults and Children: A Network Meta-Analysis.
Yang J; Wen S; Kong J; Yue P; Cao W; Xu X; Zhang Y; Chen J; Liu M; Fan Y; Luo L; Chen T; Li L; Li B; Dong Y; Luo S; Zhou G; Liu A; Bao F
Microbiol Spectr; 2021 Dec; 9(3):e0076121. PubMed ID: 34756070
[TBL] [Abstract][Full Text] [Related]
16. Lyme disease presenting as subacute transverse myelitis.
Koc F; Bozdemir H; Pekoz T; Aksu HS; Ozcan S; Kurdak H
Acta Neurol Belg; 2009 Dec; 109(4):326-9. PubMed ID: 20120216
[TBL] [Abstract][Full Text] [Related]
17. Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up.
Eliassen KE; Reiso H; Berild D; Lindbæk M
Clin Microbiol Infect; 2018 Dec; 24(12):1290-1296. PubMed ID: 29505880
[TBL] [Abstract][Full Text] [Related]
18. Would Parents Consent to a Comparative Effectiveness Trial of Oral Doxycycline Versus Intravenous Ceftriaxone for the Treatment of Children with Lyme Meningitis?
Garro A; Koster M; LaRue M; Hipolito E; Congdon E; Burnett K; Cullen N; Nigrovic LE
Pediatr Infect Dis J; 2018 May; 37(5):e140-e142. PubMed ID: 28984721
[TBL] [Abstract][Full Text] [Related]
19. Treatment of early Lyme disease.
Massarotti EM; Luger SW; Rahn DW; Messner RP; Wong JB; Johnson RC; Steere AC
Am J Med; 1992 Apr; 92(4):396-403. PubMed ID: 1313637
[TBL] [Abstract][Full Text] [Related]
20. Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.
Berende A; ter Hofstede HJ; Donders AR; van Middendorp H; Kessels RP; Adang EM; Vos FJ; Evers AW; Kullberg BJ
BMC Infect Dis; 2014 Oct; 14():543. PubMed ID: 25318999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
